131.00
-2.30
(-1.73%)
At close: January 10 at 4:36:31 PM GMT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 8 | 8 |
| Avg. Estimate | 0 | 0 | -0.18 | -0.14 |
| Low Estimate | 0 | 0 | -0.19 | -0.16 |
| High Estimate | 0 | 0 | -0.17 | -0.12 |
| Year Ago EPS | -- | -- | -0.17 | -0.18 |
Revenue Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 9 | 9 |
| Avg. Estimate | -- | -- | 183.78M | 233.68M |
| Low Estimate | -- | -- | 179M | 217.76M |
| High Estimate | -- | -- | 197.4M | 251M |
| Year Ago Sales | -- | -- | 169.67M | 183.78M |
| Sales Growth (year/est) | -- | -- | 8.32% | 27.15% |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.18 | -0.14 |
| 7 Days Ago | 0 | 0 | -0.18 | -0.14 |
| 30 Days Ago | 0 | 0 | -0.18 | -0.14 |
| 60 Days Ago | 0 | 0 | -0.18 | -0.14 |
| 90 Days Ago | 0 | 0 | -0.17 | -0.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ONT.L | -- | -- | -7.22% | 20.06% |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Related Tickers
OXB.L Oxford Biomedica plc
410.00
-0.49%
IBT.L International Biotechnology Ord
692.00
0.00%
22UA.DE BioNTech SE
119.40
+0.93%
AVBP ArriVent BioPharma, Inc.
24.88
-7.37%
HVO.L hVIVO plc
18.10
-0.55%
BVNRY Bavarian Nordic A/S
9.20
0.00%
POLB.L Poolbeg Pharma PLC
5.15
-8.04%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1056
+5.60%
0MGB.IL Genmab A/S
1,601.75
+0.28%
IXI.L IXICO plc
11.75
0.00%